Skip to content
10-Q/A

Quarterly Report

Genvor Inc GNVR

0001903596-26-000063

← back to feed
Filed
Mar 13, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Feb 11, 2026 34.43M sh
Shares Diluted Q1 2026 · Dec 31, 2025 32.76M sh
Shares Diluted Q1 2026 · Dec 31, 2024 20.67M sh
Operating Cash Flow Q1 2026 · Dec 31, 2025 −$193.65K
Operating Cash Flow Q1 2026 · Dec 31, 2024 −$1.44K
Stockholders Equity Q1 2026 · Dec 31, 2025 −$1.06M
Stockholders Equity Q1 2026 · Sep 30, 2025 −$1.31M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$1.84M
Stockholders Equity Q1 2026 · Sep 30, 2024 −$1.71M
Current Liabilities Q1 2026 · Dec 31, 2025 $1.21M
Current Liabilities Q1 2026 · Sep 30, 2025 $1.36M
Total Liabilities Q1 2026 · Dec 31, 2025 $1.21M
Total Liabilities Q1 2026 · Sep 30, 2025 $1.36M
Current Assets Q1 2026 · Dec 31, 2025 $145.74K
Current Assets Q1 2026 · Sep 30, 2025 $45.82K
Total Assets Q1 2026 · Dec 31, 2025 $145.74K
Total Assets Q1 2026 · Sep 30, 2025 $45.82K
Eps Diluted Q1 2026 · Dec 31, 2025 −$0.02
Eps Diluted Q1 2026 · Dec 31, 2024 −$0.24
Eps Basic Q1 2026 · Dec 31, 2025 −$0.02
Eps Basic Q1 2026 · Dec 31, 2024 −$0.24
Rd Expense Q1 2026 · Dec 31, 2025 $57.15K
Rd Expense Q1 2026 · Dec 31, 2024 $63.42K
Net Income Q1 2026 · Dec 31, 2025 −$576.28K
Net Income Q1 2026 · Dec 31, 2024 −$5M
Operating Income Q1 2026 · Dec 31, 2025 −$562.66K
Operating Income Q1 2026 · Dec 31, 2024 −$5M